Introducing the Novartis Declaration for Patients

preview_player
Показать описание
We are inspired by patients. This inspiration is what motivates us to discover and develop quality innovative medicines that help people live longer and better. David Epstein, head of Novartis Pharmaceuticals, explains The Novartis Declaration for Patients.
© 2015 Novartis AG
  1. Novartis
  2. “patient declaration”
  3. “leadership”
  4. “David Epstein”
  5. “novartis”
  6. “patient”
Рекомендации по теме
Introducing the Novartis 0:02:36

Introducing the Novartis Declaration for Patients

Head of Novartis 0:01:56

Head of Novartis Pharmaceuticals David Epstein Shares His Vision for the Future

Novartis Social Business: 0:02:11

Novartis Social Business: Transforming primary healthcare in Asia

How patients inspire 0:02:36

How patients inspire the work we do every day

Interview series with 0:01:38

Interview series with Novartis Chief Legal Officer (Part 6: Why is DE&I so important?)

Access to Medicine: 0:01:30

Access to Medicine: An Expert View of What It Means and Why It Matters

Novartis areas of 0:00:46

Novartis areas of focus

Data and Advanced 0:30:26

Data and Advanced Analytics Driving Innovation within Healthcare - Shruthi Bharadwaj of Novartis

Data analytics in 0:03:13

Data analytics in audit

Novartis Financial Results 0:02:36

Novartis Financial Results Q1 2020

5 Resume Mistakes 0:06:41

5 Resume Mistakes You MUST Avoid (with real examples)!

Novartis AG Company 0:00:56

Novartis AG Company Profile and Tech Intelligence Report, 2018

How To Use 0:02:43

How To Use Insulin Pen | Priming Of Insulin Pen - Medanta Hospital

Webinar: IFVI & 0:57:41

Webinar: IFVI & VBA’s General Methodology 1 - Conceptual Framework for Impact Accounting

Top Indian Pharmaceutical 0:00:06

Top Indian Pharmaceutical Companies #shorts #pharmaceuticals #viralshorts

Is Novartis Stock 0:14:55

Is Novartis Stock a Buy Now!? | Novartis (NVS) Stock Analysis! |

Building trust through 0:01:27

Building trust through partnerships - Janssen, Novartis, Lilly, ViiV

CLO Coffee Club 0:44:25

CLO Coffee Club III: Building a learning culture with Novartis [L&D Webinar]

Interview series with 0:01:46

Interview series with Novartis Chief Legal Officer (Part 2: What attracted you to Novartis?)

Novartis AG (NVS) 0:15:06

Novartis AG (NVS) Vs Bristol Myers Squibb (BMY) Stock Analysis 2021

eyeforpharma spotlight on 0:08:29

eyeforpharma spotlight on CAR T: Salesforce & Novartis

Business Analytics Team, 0:02:49

Business Analytics Team, on Careers

iCubed Seminar: Analytics 0:58:40

iCubed Seminar: Analytics Functions in Pharma with Novartis

Norvatis launches programme 0:01:15

Norvatis launches programme to treat non communicable diseases

welcome to shbcf.ru